Rigel Pharmaceuticals (RIGL) Receivables (2013 - 2026)
Rigel Pharmaceuticals (RIGL) recorded Receivables of $56.04 million in Q2 2026, up 40.4% from $39.91 million a year earlier and up 12.2% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Receivables (2013 - 2026) Analysis & Trends
At the end of FY2025, Rigel Pharmaceuticals reported Receivables of $51.76 million, up 24.4% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 26.5% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $41.62 million in FY2024 (+36.2%), $30.55 million in FY2023 (-24.2%), $40.32 million in FY2022 (+160.6%) and $15.47 million in FY2021 (-3.1%).
- The Q2 2026 figure is the highest quarterly Receivables since Q1 2021.
- On a year-over-year basis, Receivables has increased for nine consecutive quarters, with growth averaging 36.3% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 92.7% in Q1 2023, against a decline of 89.3% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $49.95 million (Q1 2026), $51.76 million (Q4 2025) and $45.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Rigel Pharmaceuticals | 801.35 Mn | 305.08 Mn | 70.11 Mn | 56.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 56.46 Mn |
| Jun 30, 2026 | 56.04 Mn |
| Mar 31, 2026 | 49.95 Mn |
| Dec 31, 2025 | 51.76 Mn |
| Sep 30, 2025 | 45.93 Mn |
| Jun 30, 2025 | 39.91 Mn |
| Mar 31, 2025 | 41.55 Mn |
| Dec 31, 2024 | 41.62 Mn |
| Sep 30, 2024 | 30.58 Mn |
| Jun 30, 2024 | 28.90 Mn |
| Mar 31, 2024 | 27.51 Mn |
| Dec 31, 2023 | 30.55 Mn |
| Sep 30, 2023 | 23.55 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 29.37 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 15.53 Mn |
| Jun 30, 2022 | 17.20 Mn |
| Mar 31, 2022 | 15.24 Mn |
| Dec 31, 2021 | 15.47 Mn |
API Access
Rigel Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();